Skip to main content
ORKASector not reported

Oruka Therapeutics, Inc. (ORKA) Insider Trading

In the last 90 days, 5 Oruka Therapeutics, Inc. (ORKA) insiders reported no open-market purchases and 16 sales totaling $22,032,752. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 20, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 20, 2026Paul T QuinlanGeneral CounselSale9,000$78.53$706,735
Oct 15, 2026Joana GoncalvesChief Medical OfficerSale7,000$74.81$523,648
Oct 12, 2026Arjun AgarwalSenior Vice President, FinanceSale9,999$80.60$805,888
Oct 1, 2026Lawrence Otto KleinChief Executive OfficerSale25,000$83.62$2,090,593
Sep 21, 2026Arjun AgarwalSenior Vice President, FinanceSale533$95.75$51,035
Sep 21, 2026Paul T QuinlanGeneral CounselSale10,000$93.64$936,417
Sep 15, 2026Joana GoncalvesChief Medical OfficerSale7,947$92.38$734,145
Sep 15, 2026Arjun AgarwalSenior Vice President, FinanceSale10,019$92.43$926,010
Sep 15, 2026Lawrence Otto KleinChief Executive OfficerSale2,452$95.71$234,681
Sep 15, 2026Paul T QuinlanGeneral CounselSale1,039$95.71$99,443

Common questions

ORKA insider trading FAQ

Are ORKA insiders buying or selling?
Over the last 90 days, ORKA insiders were net sellers, reporting $0.00 of open-market purchases and $22,032,752 of sales.
When was the last ORKA insider purchase?
No open-market insider purchase of Oruka Therapeutics, Inc. stock was reported in the last 90 days.
Where does ORKA insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Oruka Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.